Amylyx Pharmaceuticals, Inc. AMLX
Set alert
29.19 USD +1.15 +4.10%
As of Nov 3, 3:04 PM ET
28.21 Day range 29.46
11.38 52-week range 39.66
- YTD
- +141.64%
- 1 year
- +114.63%
- Open
- 28.52
- Prev close
- 28.04
- Mkt cap
- 3.66B
- Vol
- 639.37K
- Avg vol
- 2.19M
- EPS
- -1.41
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 28.21
- High
- 29.46
- Forward P/E
- -25.70
- Beta
- -0.08
- Short ratio
- 9.49
- Inst. own
- 94.36%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 30.89
- 200-d avg
- 20.08
- 1y target
- 42.64
6M chart
Events in this range
- May 7, 2026Earnings: -0.37; estimate -0.34; surprise -8.82%
- Aug 6, 2026Earnings: -0.39; estimate -0.3609; surprise -8.06%
- Aug 18, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Aug 19, 2026Rating: Baird · Outperform → Outperform
- Aug 19, 2026Rating: Guggenheim · Buy → Buy
- Aug 19, 2026Rating: Mizuho · Outperform → Outperform
- Aug 27, 2026Rating: Guggenheim · Buy → Buy
- Oct 15, 2026Rating: Citigroup · Buy → Buy
Signals (21)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 20, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 18, 2026 | 2 months ago |
| RSI: Overbought | Aug 18, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| RSI: Overbought | Aug 11, 2026 | 2 months ago |
| RSI: Overbought | Aug 4, 2026 | 3 months ago |
| RSI: Overbought | Jul 30, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 28, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| RSI: Overbought | Jul 2, 2026 | 4 months ago |
| RSI: Overbought | Jun 25, 2026 | 4 months ago |
| SMA: Bullish | Jun 17, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| MACD: Buy Signal | May 28, 2026 | 5 months ago |
| RSI: Oversold | May 18, 2026 | 5 months ago |
| SMA: Bearish | May 14, 2026 | 5 months ago |
| SMA: Bullish | May 13, 2026 | 5 months ago |
| SMA: Bearish | May 12, 2026 | 5 months ago |
Newest 20 of 21.
Held by funds
121 US ETFs and mutual funds hold AMLX · largest positions
Ownership
Held by insiders 7.16%
Held by institutions 94.36%
Float held by institutions 101.63%
Institutions 289
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 15.01% | 16,727,909 | 468.88M | Jun 29, 2026 |
| Blackrock Inc. | 7.92% | 8,827,085 | 247.42M | Jun 29, 2026 |
| Perceptive Advisors Llc | 7.48% | 8,334,882 | 233.63M | Jun 29, 2026 |
| TCG Crossover Management, LLC | 5.60% | 6,243,812 | 175.01M | Jun 29, 2026 |
| Commodore Capital Lp | 5.07% | 5,650,000 | 158.37M | Jun 29, 2026 |
| Jupiter Topco LLC | 4.70% | 5,236,102 | 146.77M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.83% | 3,154,723 | 88.43M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.42% | 2,694,093 | 75.52M | Sep 29, 2026 |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 2.18% | 2,433,200 | 68.20M | Aug 30, 2026 |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 1.90% | 2,115,961 | 59.31M | Jul 30, 2026 |
| Fidelity Select Portfolios-Select Health Care Portfolio | 1.44% | 1,600,000 | 44.85M | Aug 30, 2026 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 1.32% | 1,470,117 | 41.21M | Aug 30, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEDROSIAN CAMILLE L | Officer | Sale | Sep 9, 2026 | 278,064 |
| COHEN JOSHUA BARRY | Chief Executive Officer | Sale | Sep 9, 2026 | 3,613,120 |
| FIRESTONE KAREN M. | Director | Conversion of Exercise of derivative security | Aug 30, 2026 | 116,900 |
| FRATES JAMES MATTHEW | Chief Financial Officer | Sale | Sep 9, 2026 | 400,156 |
| KLEE JUSTIN B | Chief Executive Officer | Sale | Sep 9, 2026 | 3,613,060 |
| MAZZARIELLO GINA | Officer | Sale | Sep 9, 2026 | 190,838 |
